GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pfizer Inc (CHIX:PFEd) » Definitions » Additional Paid-In Capital

Pfizer (CHIX:PFED) Additional Paid-In Capital : €84,223 Mil(As of Sep. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Pfizer Additional Paid-In Capital?


Pfizer's quarterly additional paid-in capital increased from Mar. 2024 (€85,557 Mil) to Jun. 2024 (€86,580 Mil) but then stayed the same from Jun. 2024 (€86,580 Mil) to Sep. 2024 (€84,223 Mil).

Pfizer's annual additional paid-in capital increased from Dec. 2021 (€80,173 Mil) to Dec. 2022 (€86,661 Mil) but then declined from Dec. 2022 (€86,661 Mil) to Dec. 2023 (€84,943 Mil).


Pfizer Additional Paid-In Capital Historical Data

The historical data trend for Pfizer's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pfizer Additional Paid-In Capital Chart

Pfizer Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 78,685.20 72,890.03 80,173.04 86,661.09 84,942.63

Pfizer Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86,668.75 84,942.63 85,557.24 86,580.01 84,222.78

Pfizer Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Pfizer Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Pfizer's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Pfizer Business Description

Address
66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding covid-19-related product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer Headlines

From GuruFocus

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 08-16-2010

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-16-2009

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 11-15-2010

Park Bancorp Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 05-17-2010